The global coronavirus crisis has forever changed how and where people work. Companies all over the US have dismissed or furloughed staff, moved partially or completely to homeworking, and reorganised or disposed of their offices. And while there occasionally appears to be a flicker of light at the end of the long COVID-19 tunnel, setbacks will likely occur for some time to come.
But what does all this mean for the US office supplies industry? What is the ‘new normal’ workplace? At this critical time, it is vital for all operators in our sector to have a deep insight into what has happened in the past six months to B2B end users, but also into what they are planning for their businesses over the next 12 months, and how that will influence their OP buying decisions.
COVID-19 and Beyond: Implications for the US Office Supplies Industry is a new report researched and published by Martin Wilde Associates (MWA) and OPI respectively.
Due to be published by the end of this year, COVID-19 and Beyond will take an in-depth look at the recent past, the present as well as the future. In doing so, it will enable OP companies across the channels to plan, adjust and thrive by understanding how end users are adapting to the ‘new normal’ US workplace.
Based on approximately 400 in-depth interviews with OP buyers from various company sizes spanning the supply chain and all US geographies, the research will investigate a number of critical areas and provide answers relating to these vital issues:
- Changes in business operations in the past six months, including sales volumes, office closures and adaptations, staffing, homeworking and COVID-19 security. Also, ongoing changes over the next 12 months.
- Trends and types of SKUs purchased over the past six months as a result of the pandemic, remote working, etc, and predicted purchasing expectations over the next 12 months.
- Sources used to purchase OP items in the early stages of the pandemic, ie existing or new suppliers used, previous suppliers dropped or any supplier consolidation initiatives. Contrast this with sources expected to be used in the next 12 months.
COVID-19 and Beyond is available for $2,995 if ordered before 31 August 2020 and $3,750 thereafter. To order your copy, please visit www.opi.net/COVID